RecruitingNCT07241663

Surgery for Locally Unresectable Pancreatic Cancer

Conversion Surgery for Locally Unresectable Pancreatic Cancer - International Multi-center Observational Trial (ROBIN= suRgery for lOcally unresectaBle pancreatIc Cancer)


Sponsor

Azienda Ospedaliera di Padova

Enrollment

150 participants

Start Date

Jan 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Pancreatic cancer is a severe disease often diagnosed at an advanced stage, when surgery is not possible. New chemotherapy treatments can sometimes shrink the tumor and make surgery an option. This study aims to understand if surgery after such treatments can improve survival and quality of life in selected patients treated at expert centers.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating whether surgery can be performed on patients with locally advanced pancreatic cancer — cancer that was initially deemed inoperable — after they have received chemotherapy that shrank or stabilized the tumor. The goal is to determine whether surgery after chemotherapy leads to better outcomes. **You may be eligible if...** - You are over 18 years old with a confirmed diagnosis of pancreatic adenocarcinoma - Your cancer was initially considered locally advanced and unresectable (LAPC stage per NCCN criteria) - You have completed at least 4 months of chemotherapy and your cancer has stabilized or partially responded - A multidisciplinary team has determined you are now eligible for surgery **You may NOT be eligible if...** - You have not completed adequate prior chemotherapy - Your cancer has features that still make surgery unsafe or impossible - You have serious other medical conditions that prevent surgery - You have a different cancer type than pancreatic adenocarcinoma Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERQuestionnaire

Each enrolled patient will complete quality of life questionnaires, specifically the EORTC QLQ-C30, PAN26, and EQ-5D, at different time points: at enrollment and every 2-3 months after surgery, for up to 2 years.


Locations(1)

UOC Chirurgia Generale 2, Azienda Ospedale di Padova, Padova, Italy 35128

Padova, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07241663


Related Trials